Chem 1996;42:630-6.
19. Rasmussen K, MS')l!er J, 0stergaard K, 0stergaard
Kristensen M, Jensen J. Methylmalonic acid con–
centrations in serum of normal subjects: biological va–
riability and effect oforal L-isoleucine loads before and
after intramuscular administration of cobalarnin. Clin
Chem 1990;36:1295-9.
20. Rasmussen K, Pedersen KO, Sillesen S. Coba–
larninmangel trods normala serum-cobalarniner. Ugeskr
Laeg 1992;154:346-7.
21. Savage DG, Lindenbaum J, Stabler SP, Allen RH.
Sensitivity of serum methylmalonic acid and total
homocysteine determinations for diagnosing cobalamin
and folate deficiencies. Am JMed 1994;96:239-46.
22. Stabler SP, Allen RH, Barrett RE, Savage DG,
Lindenbaum J. Cerebrospinal fluid methylmalonic acid
levels in normal subjects and patients with cobalarnin
deficiency. Neurology 1991;41:1627-32.
Kronisk atrofisk gastrit
23. Borch K, Axelsson CK, Halgreen M, Darnkjaer
NielsenM, LedinT, Szesci PB.The ratio ofpepsinogen
A to pepsinogenC: a sensitive test for atrophic gastritis.
Scand J Gastroenterol 1989;24:870-6.
24.BurmanP,KarlssonFA,LööfL,SzesciPB,BorchK.
H•,K•-ATPase antibodies in autoimmune gastritis:
observations on the development of pemicious anemia.
Scand J Gastroenterol1991;26:207-14.
25. DeLuca Jr VA. No acid, no polyps-no "active"
gastritis, no dyspepsia. A proposal. JClinGastroenterol
1989;11:127-31.
26. Ihamäki T, Kekki M, Sipponen P, Siurala M. The
sequelae and course of chronic gastritis during a 30- to
34-year bioptic foliow-up study. Scand J Gastroenterol
1985;20:485-91.
27. Karlsson FA, Burman P, Lööf L, Mårdh S. Major
parietal cell antigen in autoimmune gastritis with
pemicious anemia is the acid-producing H+,K•-adeno–
sine triphosphatase of the stomach. J Clin Invest
1988;81:475-9.
28. Kaye MD. Immunological aspects of gastritis and
pemicious anemia [Review]. Bailliere's Clin Gast–
roenterol 1987;1:487-586.
29. Kekki M, Samloff
IM,
Varis K, Ihamäki
T.
Serum
pepsinogen I and serumgastrin in the screeningofsevere
atrophic corpus gastritis. Scand J Gastroenterol
1991;26(suppl186):109-16.
30. Krasinski SF, Russel!RM, SamloffiM, et al. Fundic
atrophic gastritis in an elderly population. J AmGeriatr
Soc 1986;34:800-6.
31. Lindstedt G, Bengtsson C, Lapidus L, Nyström E.
Hypergastrinemia-ariskfactorformyocardial infarction?
Clin Chem 1985;31:585-90.
32. LindstedtG,RunsteenD, LundbergP-A, Bengtsson
C, Lapidus L, NyströmE, Kilander AF. On the natural
history ofhypergastrinemia. Clin Chem 1985;31:1135-
40.
33. LindstedtG, LundbergP-A, JohanssonP-M, Eggert–
senR, EllertzG, NyströmE. Highprevalenceofatrophic
gastritis in theelderly: implications forhealth-associated
Klinisk Kemi
i
Norden 3, 1996
reference lirnits for cobalamin in serum [Letter]. Clin
Chem 1989;35:1557-9.
34.SipponenP,KimuraK. Intestina!metaplasia, atrophic
gastritis and stomach cancer: trends over time. Eur J
Gastroenterol Hepatol1994;6(suppll):S79-83.
35. Varis K, Samloff IM, Ihamäki T, Siurala M. An
appraisal of tests for severe atrophic gastritis in relatives
of patients with pernicious anemia. Dig Dis Sci
1979;24:187-91.
Helicobacterpylori
36. Anonym.
Helicobacter pylori
seropositivity in
myocardial infarction. Lancet 1995;345:1380.
37. DeLuca Jr VA. Is pemicious anemia eaused by
Campylobacter pylori
gastritis? J Clin Gastroenterol
1989;11:584-5.
38. IARCworkinggroupon theevaluationofcarcinogenic
risks tohumanschistosomes, liverflukes
andHelicobacter
pylori.
IARC Monogr Eva! Carcinog Risks Hum
1994;61:1-241.
39. Karnes Jr WE, Samloff IM, Siurala M, Kekki M,
SipponenP,KimSWRetal. Positive serumantibodyand
negative tissuestainingfor
Helicobacterpylori
insubjects
with atrophic body gastritis. Gastroenterology
1991;101:167-74.
40. MendallMA, Goggin PM, MolineauxN et al. Rela–
tion of
Helicobacterpylori
infection and coronary heart
disease. Br Heart J 1994;71:437-9.
41. Murray
LJ,
Barnford KB, O'Reilly DPJ, McCrum
EE, Evans AE.
Helicobacter pylori
infection: relation
withcardiovascularrisk factors, ischaemicheartdisease,
and social class.Br Heart J 1995;74:497-501.
42.Patel P,MendallMA, CarringtonDet al. Association
of
Helicobacter pylori
and
Chlamydia pneumoniae
infectionswithcoronaryheartdiseaseandcardiovascular
risk factors. BMJ 1995;311:711-4.
Behandlingmedprotonpumpshämmare
43. Kuipers EJ, UyterlindeAM, PefiaAS, et al. Increase
of
Helicabaeterpylori-associated
corpusgastritisduring
acid suppressive therapy: implications for long-term
safety. Am J Gastroenterol 1995;90:1401-1406.
44. Kuipers EJ, Lundeli L, Klinkenberg-Knol EC, et al.
Atrophic gastritis and
Helicobacter pylori
infection in
patientswith reflux esophagitis trealedwithomeprazo1e
or fundoplication. NEngl JMed 1996;334:1018-1022.
Coeliaki
45. Holmes GTK. Coeliac disease in the elderly. Gut
1994;33:65-7.
89
